Granisetron

GRANIVIB

COMPOSITION
Granisetron1MG
SPECIFICATION
FORMINJECTABLE
PACKING 1’S
PACKING TYPE
MRP80

DESCRIPTION

A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients. [PubChem]

SIDE EFFECTS

LD50>2000 mg/kg (rat, oral)

INDICATION

For the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy (including high dose cisplatin), postoperation, and radiation (including total body irradiation and daily fractionated abdominal radiation).